OSR Holdings (OSRH) Jumps Over 15% Today on Vaximm Deal Momentum: Stock Price, Nasdaq Risk and What Comes Next
OSR Holdings shares jumped about 15.5% to $0.65 in early U.S. trading Monday, with volume topping 27 million shares after subsidiary Vaximm AG signed a non-binding term sheet for its cancer vaccine platform. The stock remains over 90% below its 52-week high of $12.54 despite recent gains. Market cap stands near $17 million.
